Tanezumab improves osteoarthritis pain function in phase 3 trial

############################# Video Source: www.youtube.com/watch?v=J-wDNnLQTfA

Tanezumab, an investigational monoclonal antibody directed against nerve growth factor that is under development to treat osteoarthritis pain, met most of th...

141129, Francis Berenbaum, robert lodge, osteoarthritis, rheumatology, 3521-19
#############################